<code id='DBB7D4E330'></code><style id='DBB7D4E330'></style>
    • <acronym id='DBB7D4E330'></acronym>
      <center id='DBB7D4E330'><center id='DBB7D4E330'><tfoot id='DBB7D4E330'></tfoot></center><abbr id='DBB7D4E330'><dir id='DBB7D4E330'><tfoot id='DBB7D4E330'></tfoot><noframes id='DBB7D4E330'>

    • <optgroup id='DBB7D4E330'><strike id='DBB7D4E330'><sup id='DBB7D4E330'></sup></strike><code id='DBB7D4E330'></code></optgroup>
        1. <b id='DBB7D4E330'><label id='DBB7D4E330'><select id='DBB7D4E330'><dt id='DBB7D4E330'><span id='DBB7D4E330'></span></dt></select></label></b><u id='DBB7D4E330'></u>
          <i id='DBB7D4E330'><strike id='DBB7D4E330'><tt id='DBB7D4E330'><pre id='DBB7D4E330'></pre></tt></strike></i>

          knowledge

          knowledge

          author:hotspot    Page View:85896
          A sign of Elevance Health behind some flowers — coverage from STAT
          Michael Conroy/AP

          These days, the surefire way to get ahead in health insurance is to become a health care provider, and Elevance just upped the ante. It’s joining with private equity to launch a $4 billion primary care company.

          Elevance leaders divulged more about the company’s venture with Clayton, Dubilier & Rice on its first quarter earnings call Thursday. The partners announced the new company, yet unnamed, earlier this week, but the release was light on detail. The strategic partnership will house Elevance and CD&R’s doctors, clinics, and the technologies that help those doctors manage their patients.

          advertisement

          Health insurers specialize in managing medical costs, and through ventures like this, they apply that expertise to managing patients’ chronic medical conditions. In arrangements like Medicare Advantage, where insurers are paid set amounts for members’ care, they’re incentivized to keep those patients healthy.

          STAT+ Exclusive Story

          Already have an account? Log in

          STAT+

          This article is exclusive to STAT+ subscribers

          Unlock this article — and get additional analysis of the financial innards of our health care system — by subscribing to STAT+.

          Already have an account? Log in

          Already have an account? Log in

          Monthly

          $39

          Totals $468 per year

          $39/month Get Started

          Totals $468 per year

          Starter

          $30

          for 3 months, then $39/month

          $30 for 3 months Get Started

          Then $39/month

          Annual

          $399

          Save 15%

          $399/year Get Started

          Save 15%

          11+ Users

          Custom

          Savings start at 25%!

          Request A Quote Request A Quote

          Savings start at 25%!

          2-10 Users

          $300

          Annually per user

          $300/year Get Started

          $300 Annually per user

          View All Plans

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more
          In Gaza, a nonprofit 3D prints tourniquets and stethoscopes
          In Gaza, a nonprofit 3D prints tourniquets and stethoscopes

          Asidefromthestethoscope,thearound20-personGliateammanufacturestourniquets,earotoscopes,andcapstostop

          read more
          Medicare details structure of new drug price negotiation program
          Medicare details structure of new drug price negotiation program

          MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef

          read more

          Chemotherapy shortages won’t get better under Biden’s latest plan

          PresidentBidenspokeaboutsupplychainresilienceanddrugshortages.AlexWong/GettyImagesWASHINGTON—Preside